AnaptysBio, Inc. IPO Research Information

AnaptysBio, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on AnaptysBio, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
AnaptysBio, Inc.	ANAB - NASDAQ	$14.00-$16.00	$15.00	$16.00	5 million	1/26/2017
Underwriter(s): Credit Suisse, Stifel
Co-Manager(s): JMP Securities, Wedbush PacGrow
Industry: Health Care
Filing(s): Filed 2015-09-09 Underwriter Change 2015-12-23 Updated Prospectus 2016-12-28 Terms Added 2017-01-17

AnaptysBio, Inc. Quote & Chart - Click for current quote - ANAB

About AnaptysBio, Inc. (adapted from AnaptysBio, Inc. prospectus):
They are a biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ANAB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.